Hematologic diseases encompass a wide range of disorders affecting the blood and blood-forming organs, ranging from relatively benign conditions such as anemia, to more severe cancers of the blood. Common hematologic tumors include leukemia, lymphoma and multiple myeloma, which are characterized by the abnormal proliferation of blood cells or lymphatic tissue. These conditions necessitate specialized treatment approaches, such as chemotherapy, immunotherapy (including cellular immunotherapy), and hematopoietic cell transplantation. Timely diagnosis and tailored treatment are crucial for effectively managing these intricate hematologic diseases .Early diagnosis and personalized treatment plans are crucial for managing these complex hematologic diseases effectively.

GoBroad Healthcare Group (GHG) is a pioneer of the research-oriented hospital mode in China. We are trusted specialists in diagnosing and treating complex and serious hematologic diseases, dedicated to committed to providing high-quality, state-of-the-art healthcare at every stage of cancer treatment. Our medical services include:

• Focusing on the diagnosis and treatment of difficult and severe Hematologic Diseases such as leukemia, lymphoma, multiple myeloma, and thalassemia.
• Providing accurate diagnosis and individualized treatment. Individualizing the diagnosis and treatment plan for each patient by an effective combination of chemotherapy, radiotherapy, immunotherapy, targeted therapy, hematopoietic stem cell transplant and other technologies.
• Expanding the clinical application and research of CAR-T, innovative drugs and other advanced technologies to obtain more treatment options for refractory and relapsed patients.
• Safeguarding the whole treatment period for patients through efficient collaboration of the multidisciplinary team.

Solid tumors are abnormal masses of tissues that multiply when the cells grow and divide beyond control. They grow in organs or tissues, such as the lungs, pancreas, or gastrointestinal tract, unlike blood cancers that involve cells in the blood or bone marrow. Malignant tumors can invade other tissues and spread throughout the body, so the treatment for solid tumors needs special attention.

GoBroad Healthcare Group has a number of specialized tumor hospitals that provide multidisciplinary comprehensive diagnosis and treatments for solid tumors, including targeted immunotherapy for lung cancer, digestive system tumors. Our medical services include: 

• Focusing on the diagnosis and treatment of solid tumors such as gastrointestinal tumors, lung tumors, bone and soft tissue sarcomas, hepatobiliary and pancreatic tumors, and breast tumors.
• Integrated diagnosis and treatment and one-stop service covering the diagnosis, medicine, surgery, radiotherapy, and interventional procedure.
• Multidisciplinary care(MDC), individualizing exclusive treatment and care plans for each patient.
• Several frontier molecular targeted drugs along with immunotherapy and clinical studies of new anti-tumor drugs provide new treatment options for refractory and relapsed patients.

Patient-centered and guided by clinical needs, the GoBroad team has created a patient-driven Multidisciplinary Care (MDC) model for interdisciplinary and all-around discussion and research on the conditions and nursing measures for patients with difficult, complex, and critical tumors. This approach effectively integrates conventional therapies with innovative diagnostic and treatment technologies, enabling patients to receive more advanced, personalized, and scientifically cutting-edge treatments in a comfortable setting. It not only offers them greater chances of recovery but also enhances their quality of life significantly. These philosophies and practices have helped us to rank among the best oncology hospitals in the world.